Possibia

3603548

Last Update Posted: 2018-07-27

Recruiting status is unknown

All Genders

accepted

18 Years-70 Years

200 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Adult patients after liver transplantation initially treated with traditional Tacrolimus variant- Prograf, switched on day 10 after orthotropic liver transplantation (OLTx) on prolonged released Tacrolimus variant in 1:1 ratio ( Advagraf vs. Envarsus)

Eligibility

Relevant conditions:

Liver Transplant Rejection

Immunosuppression

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov